Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
about
Multimodal quantitative MRI assessment of cortical damage in relapsing-remitting multiple sclerosis.The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple SclerosisRapid parametric mapping of the longitudinal relaxation time T1 using two-dimensional variable flip angle magnetic resonance imaging at 1.5 Tesla, 3 Tesla, and 7 TeslaQuantitative MR Imaging of Brain Tissue and Brain Pathologies.The Use of Noncontrast Quantitative MRI to Detect Gadolinium-Enhancing Multiple Sclerosis Brain Lesions: A Systematic Review and Meta-Analysis.Quantitative T1-mapping detects cloudy-enhancing tumor compartments predicting outcome of patients with glioblastoma.A new algebraic method for quantitative proton density mapping using multi-channel coil data.In vivo MRI signatures of hippocampal subfield pathology in intractable epilepsy.Value of quantitative magnetic resonance imaging T1-relaxometry in predicting contrast-enhancement in glioblastoma patients.Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.Improved visibility of brain tumors in synthetic MP-RAGE anatomies with pure T1 weighting.The use of multiparametric quantitative magnetic resonance imaging for evaluating visually assigned lesion groups in patients with multiple sclerosis.Magnetic resonance imaging and histology correlation in the neocortex in temporal lobe epilepsy.Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI.Comparison of two quantitative proton density mapping methods in multiple sclerosis.A panel of clinical and neuropathological features of cerebrovascular disease through the novel neuroimaging methods.Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome.
P2860
Q31092111-478B24CB-07E7-481A-9A6B-113032E1287EQ31121073-4E22EF9E-F2D7-4A3C-9E3F-9A9A8ABC4F38Q35118650-11D9FD02-62C5-4447-94F2-3E47CEFF8C96Q35724467-7D072A04-2466-4629-A109-1CED4BC26D78Q36376073-091A03C2-0311-4C6F-9534-6BDB5A79DBE4Q37609463-1AF43776-CA41-4DDC-BC60-9134EA76A2D8Q38698615-21E81047-07FF-4A9F-A425-6CCD807F1AFCQ40200110-809ADE8E-2A78-4B2F-87F0-86C358EE8EF2Q41593266-6EED0351-1FC6-4AC6-8D64-00E81FF0B9C8Q48119217-E3EA7A22-7879-4254-A191-9D60C01098FEQ48184512-2DE4D4AB-42D3-49BC-9CB8-207772CEF469Q48266478-0D02ED9D-68C7-4F24-854E-8C7170325055Q48447416-050C2432-D8FF-450A-959A-C088F9D6FED0Q48495257-FA2AE97F-6A06-4B46-973A-CFAB7BBC1161Q48560597-8A4FBD41-DA7B-4985-894A-C8BF9591ED41Q49455279-593F8BC4-FB33-4CC6-9F58-BB85749D3C6FQ52148173-92949E50-E2BA-4885-ABC5-4F7EF567AFDB
P2860
Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Within-lesion differences in q ...... ncement in multiple sclerosis.
@en
Within-lesion differences in q ...... ncement in multiple sclerosis.
@nl
type
label
Within-lesion differences in q ...... ncement in multiple sclerosis.
@en
Within-lesion differences in q ...... ncement in multiple sclerosis.
@nl
prefLabel
Within-lesion differences in q ...... ncement in multiple sclerosis.
@en
Within-lesion differences in q ...... ncement in multiple sclerosis.
@nl
P2093
P2860
P50
P356
P1476
Within-lesion differences in q ...... ancement in multiple sclerosis
@en
P2093
Christoph Mayer
Christoph Schmidt
Marc Hirschmann
Marlies Wagner
Ralf Deichmann
Steffen Volz
Ulf Ziemann
P2860
P304
P356
10.1002/JMRI.24107
P577
2013-04-01T00:00:00Z